ChemPartner(SZ:300149)2022-12-07 08:24Group 1: Market Potential - The elderly market in China is significant due to the aging population, presenting a promising market outlook [3] - As people age, beneficial gut bacteria decrease, with only 5% beneficial bacteria in the elderly compared to 95% harmful bacteria in infants, indicating a high demand for products like Aliguo among seniors [3] Group 2: Business Strategy - The company has recently partnered with Weichuang Group to leverage its influence and sales channels targeting the elderly [2][3] - The transition from B2B to B2C is challenging due to a lack of experience, resources, and established sales channels, which hinders rapid growth of Aliguo sales [4] Group 3: Product Development - There are currently no plans to launch a series of products targeting different demographics; the focus is on developing a new product, "Aliguo No. 9," in collaboration with Weichuang Group [5] - The company is actively pursuing overseas business primarily in the B2B sector, which requires significant time for development and market research [5]